Dr. David Henry: We Should Be Thinking About Primary VTE Prophylaxis
Dr. David Henry: We Should Be Thinking About Primary VTE Prophylaxis
Intervew by L Scott Zoeller
20110116
2011 Feb 16
OncologySTAT Editorial Team
Dr. David Henry: We Should Be Thinking About Primary VTE Prophylaxis
OncologySTAT Editorial Team. 2011 Feb 16, Intervew by L Scott Zoeller
Abstract
Dr. David Henry is Clinical Professor of Medicine and Vice Chair, Department of Medicine at Pennsylvania Hospital; Pennsylvania Oncology Hematology Associates, Inc., Philadelphia, Pennsylvania. Introduction: Venous thromboembolism (VTE) and pulmonary embolism (PE) are leading causes of morbidity and mortality in patients with cancer. In the field of oncology, improvement has been made, not only in the treatment of DVT/PE, but also in secondary prophylaxis, such as after hospital admission or surgery....
Meet Our Experts
Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.
